Spatial Clustering and Local Risk Factors of Chronic Obstructive Pulmonary Disease (COPD)

By Chan Ta-Chien   Wang Hsuan-Wen   Tseng Tzu-Jung   Chiang Po-Huang  

International Journal of Environmental Research and Public Health, Vol. 12, Iss. 12, 2015-12 ,pp. : 15716-15727

MDPI

Access to resources Recommend Favorite

Asymmetric Dimethylarginine in Chronic Obstructive Pulmonary Disease (ADMA in COPD)

By Scott Jeremy A.   Duongh MyLinh   Young Aaron W.   Subbarao Padmaja   Gauvreau Gail M.   Grasemann Hartmut  

International Journal of Molecular Sciences, Vol. 15, Iss. 4, 2014-04 ,pp. : 6062-6071

MDPI

Access to resources Recommend Favorite

Adiponectin: An Attractive Marker for Metabolic Disorders in Chronic Obstructive Pulmonary Disease (COPD)

By Bianco Andrea   Mazzarella Gennaro   Turchiarelli Viviana   Nigro Ersilia   Corbi Graziamaria   Scudiero Olga   Sofia Matteo   Daniele Aurora  

Nutrients, Vol. 5, Iss. 10, 2013-10 ,pp. : 4115-4125

MDPI

Access to resources Recommend Favorite

DNA Damage Due to Oxidative Stress in Chronic Obstructive Pulmonary Disease (COPD)

By Neofytou Eirini   Tzortzaki Eleni G.   Chatziantoniou Argiro   Siafakas Nikolaos M.  

International Journal of Molecular Sciences, Vol. 13, Iss. 12, 2012-12 ,pp. : 16853-16864

MDPI

Access to resources Recommend Favorite

Management of Clinical Failures in Non-ICU Patients with Chronic Obstructive Pulmonary Disease Exacerbations

By  

Chemotherapy, Vol. 47, Iss. 4, 2001-09 ,pp. : 39-46

Karger

Access to resources Recommend Favorite